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Abstract
 
Invariant natural killer T (NKT) cells are a highly conserved subset of T lymphocytes express-
ing a semi-invariant T cell receptor (TCR), which is restricted to CD1d and specific for the
glycosphingolipid antigen 
 
 
 
-galactosylceramide. Their ability to secrete a variety of cytokines,
which in turn modulate the activation of cells of both innate and acquired immune responses,
suggests that invariant NKT cells exert a regulatory role mainly via indirect mechanisms. A rel-
evant question is whether invariant NKT cells can directly help B cells. We document here
that human invariant NKT cells are as efficient as conventional CD4
 
 
 
 Th0 lymphocytes in
promoting proliferation of autologous memory and naive B lymphocytes in vitro, and in in-
ducing immunoglobulin production. Help to B cells by invariant NKT cells is CD1d-depen-
dent and delivered also in the absence of 
 
 
 
-galactosylceramide, suggesting that NKT cells rec-
ognize an endogenous ligand presented by CD1d on B cells. The two major subsets of
invariant NKT cells, CD4
 
 
 
 and double negative (CD4
 
 
 
CD8
 
 
 
), express comparable levels of
CD40 ligand and cytokines, but differ in helper functions. Indeed, both subsets induce similar
levels of B cell proliferation, whereas CD4
 
 
 
 NKT cells induce higher levels of immunoglobu-
lin production. These results suggest a direct role for invariant NKT cells in regulating B lym-
phocyte proliferation and effector functions.
Key words: autoreactivity • cytokine • 
 
 
 
-galactosylceramide • antibodies • helper assay
 
Introduction
 
NKT cells are a heterogeneous subset of T lymphocytes,
displaying a CD4
 
 
 
 or CD4
 
 
 
CD8
 
 
 
 double negative (DN)
 
*
 
phenotype, and coexpressing the natural killer receptor
NK1.1/NKRP1A (CD161) and a semi-invariant TCR,
encoded in mice and humans by the homologue invariant
V
 
 
 
14-J
 
 
 
281 and V
 
 
 
24-J
 
 
 
Q rearrangements, respectively
(1–4).
Both mouse and human invariant NKT (inv. NKT) cells
recognize the highly conserved MHC class I–like molecule
CD1d (5). Although natural antigens presented by CD1d
to inv. NKT cells are still unknown, 
 
 
 
-galactosylceramide
(
 
 
 
-GalCer), a glycosphingolipid isolated from marine
sponges, specifically binds CD1d, and activates mouse and
human inv. NKT cells (6, 7).
Because of their homogeneous TCR repertoire and acti-
vated/effector phenotype, inv. NKT cells are regarded as
actors of innate immune response (8, 9). Results obtained
so far point toward a regulatory role for inv. NKT cells,
determined by their capacity to promptly secrete high
amounts of diverse cytokines upon TCR engagement,
leading in turn to a variety of effects on the immune system
(1). These effects go from NK cell activation (10) to helper
T cell differentiation (11). A still unresolved question is
whether inv. NKT lymphocytes help B lymphocytes pro-
liferation and antibody production. Most mouse and hu-
man B cells express CD1d and data obtained in mice in-
deed suggest that interactions between CD1d expressed on
B cells and CD1d-restricted T cells may play a role in de-
termining amount, isotype, and specificity of the antibodies
produced (3, 12, 13). Nevertheless, attempts to demon-
strate specifically that inv. NKT cells help CD1d-depen-
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dent antibody responses have produced conflicting results
in mice (14, 15) while nothing is known in humans.
As antibodies are an essential part of many immune re-
sponses, to address this question, we have generated a panel
of inv. NKT cell clones and tested their ability to trigger
autologous B cells proliferation and effector functions.
Here we show that human inv. NKT cells promote pro-
liferation of memory and naive B lymphocytes, and immu-
noglobulin production. Help is mediated by CD1d recogni-
tion on B cells, and occurs also in the absence of 
 
 
 
-GalCer.
 
Materials and Methods
 
Antibodies and Flow Cytometry.
 
FITC, PE, PerCP, APC, Cy5,
or biotin-conjugated anti-V
 
 
 
11 (C21), anti-V
 
 
 
24 (C15) (Im-
munotech); anti-CD1d (CD1d42), anti-CD3 (SK7), anti-CD4
(RPA-T4), anti-CD8 (SK1), anti-CD14 (M5E2), anti-CD62L
(DREG56), anti-CD20 (L27), anti-CD27 (L128), anti-CD161
(BX12), anti-IFN-
 
 
 
 (25723.11), anti-IL-4 (3010.211), anti-IL-13
(JES10–5A2), anti-TNF-
 
  
 
(6401.1111), and isotype controls were
from BD Biosciences; PE-anti-CCR7 (150503) was from R&D
Systems; PECy7-streptavidin was from CALTAG.
Four- and five-color flow cytometric analysis was performed
using a LSR
 
®
 
 or a FACSVantageSE DiVaOption
 
® 
 
instrument
(Becton Dickinson), respectively.
 
Invariant NKT and T Cell Clones.
 
PBMCs, obtained from
peripheral blood of three healthy volunteers, were plated at 10
 
6
 
cells/ml in RPMI (GIBCO BRL) containing 10% FCS (Hy-
Clone), 
 
 
 
-GalCer (50 ng/ml; KRN7000, Kirin Brewery Co.,
Gumna, Japan, supplied to P. Dellabona) and 100 U/ml of re-
combinant h-IL-2 (100 U/ml; Chiron Corp.). At day 15,
V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
CD4
 
 
 
CD8
 
 
 
, V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
CD4
 
 
 
CD8
 
 
 
, or
V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
CD4
 
 
 
CD8
 
 
 
 cells were cloned with a FACSVan-
tageSE
 
® 
 
using CloneCytePlus
 
®
 
 software, in Terasaki plates (Rob-
bins) containing irradiated PBMC, PHA (0.5 
 
 
 
g/ml; Sigma-
Aldrich),  and recombinant h-IL-2. Clones were restimulated
with the same reagents every 15–20 d.
 
Screening of Inv. NKT and T Cell Clones for 
 
 
 
-GalCer Specifi-
city.
 
NKT or T cells (2.5 
 
 
 
 10
 
5
 
/ml) and 2.5 
 
 
 
 10
 
5
 
/ml irradiated
autologous CD19
 
 
 
 cells were cultured with 0.2 
 
 
 
g/ml anti-CD3
(UCHT1; BD Biosciences), 50 ng/ml of 
 
 
 
-GalCer or equivalent
amounts of DMSO or mouse IgG1 (Sigma-Aldrich). After 48 h,
cell proliferation was assessed by adding 1 
 
 
 
Ci/well of 
 
3
 
[H]-thy-
midine for additional 16 h. 6 V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
CD4
 
 
 
 
 
 
 
-GalCer-
unreactive T cell clones and 12 V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
 
 
 
 
-GalCer–reactive
NKT cell clones (6 CD4
 
 
 
, 6 CD4
 
 
 
) were expanded for this
study. The presence of canonical V
 
 
 
24-J
 
 
 
Q rearrangement in
V
 
 
 
24
 
 
 
V
 
 
 
11
 
 
 
 NKT cell clones was confirmed by PCR-hetero-
duplex analysis as described (9).
 
B Lymphocyte’s Purification.
 
Autologous CD19
 
 
 
 cells were
purified from PBMCs of the three healthy donors, with anti-
CD19 magnetic beads (Miltenyi Biotec) following manufacturer’s
instructions. All preparations were 99% CD20
 
 
 
, the few contam-
inating cells being CD14
 
 
 
.
 
Helper Assays.
 
B lymphocytes (2.5 
 
 
 
 10
 
5
 
/ml) were cultured
alone or with irradiated NKT cells (2.5 
 
 
 
 10
 
5
 
/ml), with 0.2 
 
 
 
g/
ml anti-CD3, 50 ng/ml of 
 
 
 
-GalCer, or equal amounts of mouse
IgG1 or DMSO. After 5 d 
 
3
 
[H]-thymidine incorporation by B
cells was assessed. Immunoglobulin concentration in supernatants
was determined at day 10 by ELISA using the following antibod-
ies (BD Biosciences): clones JDC-15 and G20–127 (for IgM);
clones G18–145 and G17–1 (for IgG1); clones G7–18 and G7–26
 
(for IgE). Standard human IgG1 and IgM were from Sigma-
Aldrich; IgE from Calbiochem.
 
Carboxyfluorescein-Diacetate-Succinimidyl Ester Dilution.
 
B cells
were loaded with carboxyfluorescein-diacetate-succinimidyl ester
(CFDA-SE; Molecular Probes) and cultured at 5 
 
 
 
 10
 
5
 
/ml in the
presence or in the absence of 2.5 
 
 
 
 10
 
4
 
/ml non-irradiated inv.
NKT cells and the following reagents: 
 
 
 
-GalCer (50 ng/ml);
anti-CD40 (10 
 
 
 
g/ml, agonistic, 626.1), IL-4 (5 ng/ml; R&D
System), IL-2 (100 U/ml), anti-CD1d (10 
 
 
 
g/ml, CD1d42), anti–
IL-4 and/or anti–IL-13 (10 
 
 
 
g/ml, MP425D2 and JES105A2;
R&D Systems), anti-CD40 mAb (10 
 
 
 
g/ml, antagonistic, mu5D12;
reference 16). The presence of dead cells was excluded by run-
ning parallel propidium iodide-stained samples.
 
Statistical Analysis.
 
Statistical analysis was performed using the
paired Student’s 
 
t
 
 test. 
 
*
 
 and 
 
**
 
 indicate P 
 
  
 
0.05 and P 
 
  
 
0.01
against medium, respectively.
 
Results
 
Human CD4  Inv. NKT Cell Clones Promote Activation
and Proliferation of Both Naive and Memory B Lymphocytes
Even in the Absence of  -GalCer. To assess whether CD4 
inv. NKT cells were able to help B lymphocytes, autolo-
gous B cells were purified from peripheral blood and ana-
lyzed for the expression of the memory marker CD27 (17)
and of the NKT cell restriction molecule CD1d. No differ-
ences in CD1d expression were observed between naive
(CD27 ) and memory (CD27 ) B cell subsets (Fig. 1 A).
Purified B cells were then cultured with cytokines or an
agonistic anti-CD40 mAb or autologous CD4  inv. NKT
cell clones with or without  -GalCer. B cell proliferation
was determined after 5 d, by assessing the dilution of the
CFDA-SE dye in CD27  and CD27  B cell subsets. No
significant B cell proliferation was observed in response to
IL-2 plus IL-4, indicating that B cells were not preactivated
(unpublished data). In the presence of an agonistic anti-
CD40 mAb, B cell division was detected, but was mainly
restricted to the memory subset (Fig. 1 B, panel I). When B
cells were cocultured with inv. NKT cell clones, both
CD27  and CD27  B lymphocytes divided (Fig. 1 B, pan-
els II and III). Although maximal proliferation was ob-
served in the presence of both inv. NKT cells and  -Gal-
Cer (Fig. 1 B, panel lII), we also observed significant cell
division when B cells and inv. NKT cells were cocultured
without  -GalCer (Fig. 1 B, panel II). B cell proliferation
induced by inv. CD4  NKT cells, with and without
 -GalCer, was almost completely inhibited by a neutraliz-
ing anti-CD1d antibody.
The role played by cytokines and CD40-CD40L in
B-NKT cell interactions was analyzed by adding neutral-
izing antibodies (Fig. 1 B, panels II and III). When added
individually, anti-IL-4 and IL-13 mAbs failed to exert any
effect (unpublished data), while they inhibited B cell prolif-
eration when combined, both in the presence and in the
absence of  -GalCer (Fig. 1 B, panel II and III). Con-
versely, an antagonistic anti-CD40 mAb did not reduce the
total number of proliferating B lymphocytes, although it
induced some reduction in the number of cells undergoing
three or more cell divisions (Fig. 1 B, panel II and III).T
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From the above experiments we conclude that CD4 
inv. NKT cells induce proliferation of both naive and
memory B cells even in the absence of  -GalCer in a
CD1d-restricted manner.
Human CD4  Inv. NKT Cells Help Immunoglobulin Pro-
duction. To assess the ability of CD4  inv. NKT cells to
support immunoglobulin production, autologous puri-
fied B lymphocytes were cultured with irradiated CD4 
inv. NKT cell clones in the presence of the polyclonal T
cell stimulus anti-CD3 or of the inv. NKT–specific anti-
gen  -GalCer. After 10 d, we measured the presence of
IgM, IgG1, and IgE in culture supernatants. As shown in
Fig. 2, IgM (Fig. 2 A) and IgG1 (Fig. 2 B) production
was induced by CD4  inv. NKT cell clones activated by
anti-CD3 or by  -GalCer, while IgE were never de-
tected (data not depicted). When inv. NKT cells were
activated by  -GalCer, but not by anti-CD3, the subse-
quent immunoglobulin production by B cells was inhib-
ited by an anti-CD1d antibody. Interestingly, CD4  inv.
NKT cells helped low but significant levels of IgM (but
not IgG1) production by autologous B cells in the ab-
sence of any T cell activation stimuli. Also in this case,
antibody production was inhibited by a neutralizing anti-
CD1d antibody.
These results further demonstrated that human inv.
NKT cells, probably recognizing a yet unidentified ligand,
can help autologous B cells in the absence of  -GalCer.
Human CD4  and DN Inv. NKT Cells Provide Similar
Help for B Cell Proliferation, Whereas CD4  NKT Cells Pref-
erentially Sustain Immunoglobulin Production. It has been
described that CD4  and DN human inv. NKT cells dis-
play different cytokine profiles, with the DN subset pro-
ducing higher levels of IFN- , TNF- , and perforin, but
little IL-4 and IL-13 (2). To assess whether these two
NKT cell subsets display different helper activity, we first
compared phenotype and cytokine production of CD4 
and DN inv. NKT cell clones with those of conventional
CD4  Th0 cell clones obtained from the same individu-
als. When activated with PMA and ionomycin, the three
T cell subsets expressed similar levels of CD40L (Fig. 3 A)
and comparable patterns and levels of cytokines (Fig. 3
B). Consistently, the two subsets of inv. NKT cells in-
duced similar levels of B cell proliferation (Fig. 3 C)
when activated by anti-CD3 or  -GalCer. By contrast,
Figure 1. Human CD4  inv. NKT cell clones induce CD1d-dependent proliferation of naive and memory B lymphocytes in the presence and in the
absence of  -GalCer. (A) Expression of CD1d and CD27 on freshly isolated B lymphocytes from one representative healthy donor out of three analyzed.
(B) CFDA-SE-dilution on CD27  and CD27  B lymphocytes (CD20 CD3 ) after 5 d in culture with the indicated reagents, alone (panel I) or together
with CD4  inv. NKT cells in the absence (panel II) or in the presence (panel III) of  -GalCer. Samples run in the presence of isotype-matched control
mAbs gave no differences above medium. Results are from one experiment out of three, in which three CD4  NKT cell clones were tested in parallel
giving comparable results. For each sample, 3   105 events in the lymphocyte region were acquired.T
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CD4  inv. NKT cells were significantly more efficient
than the DN ones in eliciting IgM and IgG1 production
(Fig. 3, D and E).
We conclude that CD4  and DN NKT cells differ in
their ability to support immunoglobulin production de-
spite their comparable CD40L expression and cytokine
production.
Human CD4 CCR7 CD62L  NKT Cells Expand in
Response to  -GalCer. One possible site, where inv. NKT
and B cells can interact, is lymphoid tissue. As recently de-
scribed, very few circulating human V 24 V 11  T cells
express the lymphoid tissue homing receptors CCR7 and
CD62L, and these cells belong only to the CD4  subset
(18). To assess whether CCR7 CD62L V 24 V 11  cells
were “canonical” inv. NKT cells, we determined the ex-
pression of CCR7 and CD62L on V 24 V 11  CD4  and
CD4  cell subsets, before and after stimulation with  -Gal-
Cer. As shown in Fig. 4 A, CD4  V 24 V 11  cells coex-
pressed CCR7 and CD62L at similar levels ex vivo (day 0)
and after 2 wk of culture in the presence of  -GalCer. No
coexpression of CCR7 and CD62L was found in the CD4 
subset of V 24 V 11  cells at any time point (Fig. 4 A).
To confirm that the CD4 CCR7 CD62L   V 24 
V 11  subset expands in response to  -GalCer stimula-
tion, and not because of bystander activation mechanisms,
the CD4 CCR7 CD62L  lymphocyte subset was sorted
from PBMCs of three healthy subjects, and analyzed for
the presence of NKT cells before and after  -GalCer stim-
ulation. While V 24 V 11  cells were virtually undetect-
able in the freshly sorted population, they were found in a
sizeable fraction after one and two weeks of culture with
 -GalCer (Fig. 4 B).
From these results we conclude that a small fraction of
circulating CD4  inv. NKT cells is equipped with appro-
priate lymphoid tissue–homing receptors and can theoreti-
cally encounter B cells in lymph nodes.
Discussion
This study demonstrates that human inv. NKT cells can
provide direct help to autologous B lymphocytes, inducing
proliferation of naive and memory B cells and immuno-
globulin production.
Productive interaction between inv. NKT cells and B
lymphocytes requires CD1d molecules on B cell surface.
Notably, inv. NKT cells react to CD1d expressed on pri-
mary B lymphocytes even in the absence of  -GalCer.
This “auto-reactivity” toward CD1d molecules, although
new for NKT-B cell interactions, has been described for
NKT cells interacting with tumor cell lines transfected
with CD1d, when NKT lymphocytes are pretreated with
suboptimal doses of PMA (3, 4). The use of autologous
inv. NKT and B cells allowed to exclude any form of al-
loreactivity in NKT–B cell interactions occurring in the
absence of  -GalCer. Although we cannot formally rule
out carry over of  -GalCer used in the original stimula-
tion of peripheral blood lymphocytes from which NKT
cell clones were generated, two reasons make this “carry
over” extremely unlikely. First, inv. NKT cell clones were
used after at least 20 d of culture without any exogenous
 -GalCer. Second, and most importantly, all clones used
were CD1d negative. Therefore, we favor the hypothesis
that B cells express an endogenous glycolipid other than
 -GalCer, associated to CD1d and recognized by NKT
cells.
What is the functional relevance of inv. NKT cell help?
The requirement of CD1d as restriction element for NKT–B
cell interactions parallels MHC class II requirement ob-
served in T-B cell cognate interactions. The classical
MHC-II–dependent “cognate help” requires BcR-medi-
ated antigen internalization and presentation of specific
epitopes to antigen-specific T cells (19). Possibly, interac-
tions with inv. NKT cells are restricted in vivo to B cells
producing antibodies against glycosphingolipid antigens
that would be captured, internalized, and presented in the
CD1d context.
Alternatively, based on our observations in vitro, inv.
NKT cells may recognize B cells expressing a “yet un-
known” endogenous ligand associated to CD1d, regardless
of their BcR specificity. This possibility would require
Figure 2. Human CD4  inv. NKT cell clones provide CD1d-depen-
dent help to B lymphocytes for immunoglobulin production. IgM (A)
and IgG1 (B) released by B lymphocytes cultured with irradiated CD4 
inv. NKT cell clones, the indicated stimuli and a neutralizing anti-CD1d
or an isotype control mAb. Values are the mean   SE from three inde-
pendent experiments, each performed with three CD4  inv. NKT cell
clones. P values between anti-CD1d- and isotype control-treated samples
are indicated above the lines.T
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strict control to avoid generalized B cell activation. For in-
stance, inv. NKT cells might help B cells in which CD1d
presents endogenous ligands that are synthesized by B cells
upon stimuli such as inflammatory/innate signals via Toll–
like receptors (20).
Secondary lymphoid organs are the anatomical sites were
T helper and B cells meet (21). Circulation of T cells
within lymphoid tissues depends on the expression of spe-
cific sets of homing receptors, i.e., chemokine receptors
CXCR5, CCR7, and the adhesion molecule CD62L (22).
We show here that a small fraction of CD4  inv. NKT
cells expresses CCR7 and CD62L, and retains them after
 -GalCer–specific activation. Therefore, intranodal inter-
actions may occur between CD4  inv. NKT cells and a
subset of CD1d-expressing B cells. Interestingly, the fre-
quency of inv. NKT cells in lymph nodes, spleen, and pe-
ripheral blood is similar, and a significant percentage of
intranodal B cells expresses CD1d (our unpublished obser-
vations). Conversely, given that the great majority of
inv. NKT cells is equipped with the CXCR3 and CCR5
homing receptors for inflamed tissues (18), extranodal in-
teraction between inv. NKT cells and B cells is also likely
to occur in inflamed nonlymphoid tissues. In this case, inv.
NKT cells activated by B cells that have migrated into in-
flammation sites may contribute to the local immune re-
sponse, even if the inflamed tissue is CD1d negative. Con-
sequently, CD1d dependent interactions between inv.
NKT and B cells would result also in activation of B cells
proliferation and/or immunoglobulin production. Ectopic
lymphoid follicles containing activated B cells are often
found in tissues chronically inflamed because of autoim-
mune diseases (23) or viral infections (24). It is tempting to
speculate that inv. NKT cells play an active role in B cell
activation at the inflammation sites. Indeed, lymphoid ag-
gregates detected in the liver peri-portal spaces of patients
with chronic hepatitis C, contain many B cells expressing
CD1d (our unpublished observations).
CD4  and DN inv. NKT cells show comparable abil-
ity to promote B cell proliferation, whereas the CD4 
subset is superior in helping immunoglobulin production.
This finding may imply a different role for these two inv.
NKT cell subsets in the regulation of B cell responses.
While CD4  NKT cells can help true humoral responses
under physiological conditions, DN NKT cells might
play a regulatory role on B lymphocyte activation at in-
flammation sites. Accordingly, the few circulating inv.
Figure 3. Human CD4  and DN inv. NKT cell clones help similarly B cell proliferation, but only CD4  NKT cell clones sustain immunoglobulin
production. The expression of CD40L (A) and intracellular cytokines (B) was compared on conventional CD4  Th0 cells, CD4 , and DN inv. NKT
cells. For all samples, 104 events in the lymphocyte region were acquired. Results are from one clone representative of six for each group. B lymphocytes
proliferation (C), IgM (D), and IgG1 (E) production after stimulation by irradiated CD4  T cells (gray bars), CD4  (open bars), or DN (black bars) inv.
NKT cells in the presence of the indicated stimuli (basal levels have been subtracted). Values are the mean   SE from three independent experiments in
which six clones for each group were tested. P values between samples activated with the three groups of clones are indicated.T
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NKT cells equipped with appropriate lymphoid tissue-
homing receptors are CD4  (18), further underscoring
the possibility that, physiologically, this subset and not
the DN one contains NKT cells endowed with full
helper effector functions.
While inv. NKT cells produce both IFN-  and IL-4, it is
unclear whether their effector functions influence adaptive
immune responses toward Type 1 or Type 2 responses. In our
experimental system, inv. NKT cells, like conventional CD4 
Th0 cells, did not induce detectable IgE production (the hall-
mark of a Th2 response). This finding is in agreement with the
reduction of IgE levels observed in sera of mice injected with
 -GalCer (25), but contrast with other studies showing that
repeated inoculation of  -GalCer in mice increases IgE pro-
duction in the context of a global Th2-switch of the immune
response (11, 26). These discrepancies probably reflect differ-
ences in the various experimental settings that could favor co-
stimulatory pathways required by inv. NKT cells to preferen-
tially produce Th1 or Th2 cytokines (27).
The role played by NKT cells in regulating B cell re-
sponses should be now investigated in depth in different
models, especially as our finding that NKT cells help B
cells in the absence of  -GalCer suggests a regulatory role
of NKT cells on B cell physiology.
This study has been funded by the Italian Association for Cancer
Research (AIRC), the Human Frontiers Science Program (HFSP,
RG00168/200-M), European Union (QLK2-CT-2001-01205),
and Italian Ministry of Health.
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Figure 4. Human CD4 CCR7 CD62L  inv. NKT cells expand in response to  -GalCer. CCR7 and CD62L (A) expression on
CD4 V 24 V 11  and CD4 V 24 V 11  PBMCs, before and after 2 wk in culture with  -GalCer. Expression of CCR7 and CD62L on total CD4
lymphocytes is also shown. Expansion of inv. NKT cells (B) from the CD4 CCR7 CD62L  subset sorted from PBMCs or tonsils and stimulated with
 -GalCer and irradiated autologous B lymphocytes. Sorting was performed according to the indicated gates. For each sample 2   105 to 2   106 events
in the lymphocyte region were acquired. Results are from one out of three representative donors.T
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